Drug Trial Radar · NCT02446132
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Last checked: Nov 19, 2026Latest source record: Oct 15, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
1,197
Actual
Start
Nov 13, 2015
Primary completion
Sep 6, 2024
Study completion Sep 6, 2024
Sponsor
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.Otsuka
- Sponsor type
- Industry
- First posted
- May 18, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This was an extension study of the Phase 3 Studies 15-AVP-786-301, 15-AVP-786-302, and 17-AVP-786-305.
Conditions
- Agitation in Patients With Dementia of the Alzheimer's Type
Interventions
AVP-786Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Treatment-Emergent Adverse Events (TEAEs)Time frame: From first dose of study drug (in current study) up to 3 months after last dose of study drug (up to Week 64)
- Number of Participants With Serious TEAETime frame: From first dose of study drug (in current study) up to 3 months after last dose of study drug (up to Week 64)
- Number of Participants With Potentially Clinically Significant Laboratory Test AbnormalitiesTime frame: Baseline (current study) up to 52 weeks
- Number of Participants With Potentially Clinically Significant 12-lead Electrocardiogram (ECG) AbnormalitiesTime frame: Baseline (current study) up to 52 weeks
- Number of Participants With Any Abnormal, Clinically Significant Physical and Neurological Examination FindingTime frame: Baseline (current study), Week 52
- Number of Participants With Potentially Clinically Significant Abnormalities in Vital SignsTime frame: Baseline (current study) up to 52 weeks
- Change From Baseline in the Sheehan Suicidality Tracking Scale (S-STS) Total Score at Week 64Time frame: Baseline (current study), Week 64
- Change From Baseline in the Mini-Mental State Examination (MMSE) Score at Week 52Time frame: Baseline (current study), Week 52
- Change From Baseline in the Epworth Sleepiness Scale (ESS) Score at Week 52Time frame: Baseline (current study), Week 52
Locations
227 sites in 10 countries. Site status is shown where the registry gives one.
MD First Research, LLC Site #767
Chandler, Arizona
NoesisPharma, LLC
Phoenix, Arizona
Perseverance Research Center, LLC
Scottsdale, Arizona
Health Initiatives Research
Fayetteville, Arkansas
Advanced Research Center, Inc. Site #835
Anaheim, California
ATP Clinical Research, Inc. Site #763
Costa Mesa, California
Behavioral Research Specialists, LLC
Glendale, California
Irvine Center for Clinical Research
Irvine, California
Sheenath Clinical Service Site #770
Lakewood, California
Torrance Clinical Research Institute, Inc. Site #826
Lomita, California
Collaborative Neuroscience Network, LLC.
Long Beach, California
Alliance for Wellness, Inc dba Alliance for Research Site #789
Long Beach, California
NRC Research Institute
Orange, California
California Neurological Services
Panorama City, California
Havana Research Institute Site 787
Pasadena, California
Havana Research Institute
Pasadena, California
Pacific Research Network, Inc. #1
San Diego, California
Pacific Research Network, Inc. #2
San Diego, California
HB Clinical Trials Inc.
Santa Ana, California
Syrentis Clinical Research
Santa Ana, California
Viking Clinical Research
Temecula, California
Lytle and Weiss, PLLC dba Clinical Trials of the Rockies
Denver, Colorado
Coastal Connecticut Research, LLC
New London, Connecticut
Research Center for Clinical Studies, Inc.
Norwalk, Connecticut
Neurology of Central Florida Rsch Ctr Site #803
Altamonte Springs, Florida
JEM Research Institute
Atlantis, Florida
Negron Research Services / Humanity Clinical Research Site# 766
Aventura, Florida
SFM Clinical Research, LLC Site #563
Boca Raton, Florida
Bradenton Research Center Site #834
Bradenton, Florida
Clinical Research Of Brandon, LLC Site #838
Brandon, Florida
Clinical Research of Brandon
Brandon, Florida
Meridien Research
Brooksville, Florida
Quantum Laboratories, Inc.
Deerfield Beach, Florida
Moonshine Research Center, Inc
Doral, Florida
Science Connections, LLC Site #814
Doral, Florida
Finlay Medical Research Corp
Greenacres City, Florida
Direct Helpers Research Center #801
Hialeah, Florida
Indago Research & Health Center, Inc.
Hialeah, Florida
New Life Medical Research Center, Inc.
Hialeah, Florida
Reliable Clinical Research,LLC
Hialeah, Florida
Showing 40 of 227 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.